Background: Background: We have reported previously that, compared with use of second
generationn oral contraceptives, the use of third generation oral contraceptives iss …

Background We have reported previously that, compared with use of second-generation oral
contraceptives, the use of third-generation oral contraceptives is associated with increased …

Recent studies suggest that low‐dose oral contraceptives may cause acquired resistance to
activated protein C (APC). The aims of this study were to determine whether hormone …

Combined oral contraceptives show clear differences in effect on the tissue factor-initiated
coagulation test of activated protein C resistance, which is dependent on the presence and …

Using a newly-developed technique, a severe acquired plasma resistance to activated
protein C has been described in women using third-generation (rather than second …

Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using third …

Resistance to activated protein C (APC) is often associated with a mutation in factor V (factor
VLeiden). Individuals without factor VLeiden who exhibit a response in functional APC …

Activated protein C (APC) resistance, determined with a thrombin‐generation‐based APC
resistance test, may explain risk differences of venous thrombosis in users of second‐and …

Resistance to activated protein C (APC resistance) is an important and common risk factor
for deep vein thrombosis. The majority of patients with APC resistance carry a mutation on …

Background: Oral contraceptives (OC) containing different types of progestogens induce
different sensitivities to activated protein C (APC) measured with the thrombin generation …